Stanford researchers have developed a novel method to process raw genomic sequencing data into deep learning models directly, eliminating the dependency on genome assemblies with applications in drug discovery and diagnostics.
Stanford researchers in Dr. Taia Wang's lab have developed a technology that utilizes swainsonine to enhance the cytotoxic potency of monoclonal antibodies, thereby improving their efficacy in cancer and autoimmune disease treatments.
Stanford scientists have developed an advanced optical technology that can separate and recombine thousands of extremely close light frequencies with unprecedented precision.
According to the National Center of Drug Abuse, over 9M Americans misuse opioids in a year, leading to over 106,000 deaths in 2021. Up to 10% of surgical patients develop opioid dependence after surgery.
Stanford University researchers have developed methods for depositing diamond on substrates. The method allows controlled growth of the diamond to produce useful diamond films.
Stanford researchers have patented a real-time auralization-reverberation system (CAVIAR - Chamber for Augmented Virtual and Interactive Audio Realities) for providing immersive and interactive audio environments.
Stanford researchers have developed a networked audio system that enhances the experience of teleconferencing, and online performances, gaming, and gatherings.
Stanford scientists have developed waterproofed six-axis robotic Stewart platforms that accurately replicate papillary muscle motion in ex vivo heart simulators.
Stanford scientists have developed a strategy that enables simultaneous and combinatorial genetic screening across different types of genetic perturbations (gene knockouts, knock-ins, overexpression, and gene domain modification).
Stanford researchers have developed a strategy for generating chimeric transcription factors that enables exhaustion-resistant CAR-T cells and can be generalized to a wide range of cell therapies.
Stanford researchers have developed a strategy for engineering next-generation cell therapies where gene knock-in is tightly coupled to gene knockout, preventing dangerous side effects associated with cells that have the knockout in the absence of the knock-in and vice versa.
Stanford scientists have engineered synthetic surface receptors that combine domains from diverse natural receptors to enhance T cell function in challenging immunotherapeutic contexts.
Stanford scientists have developed engineered transcription factors that enhance T cell function and prevent exhaustion by systematically combining functional protein domains.